Prosecution Insights
Last updated: April 19, 2026
Application No. 17/530,409

MECHANICAL CIRCULATORY SUPPORT SYSTEM WITH INSERTION TOOL

Final Rejection §102§103§DP
Filed
Nov 18, 2021
Examiner
TEHRANI, DANIEL
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Kardion GmbH
OA Round
4 (Final)
58%
Grant Probability
Moderate
5-6
OA Rounds
3y 9m
To Grant
99%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allow Rate
28 granted / 48 resolved
-11.7% vs TC avg
Strong +44% interview lift
Without
With
+43.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
35 currently pending
Career history
83
Total Applications
across all art units

Statute-Specific Performance

§101
5.5%
-34.5% vs TC avg
§103
47.3%
+7.3% vs TC avg
§102
21.2%
-18.8% vs TC avg
§112
22.6%
-17.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 48 resolved cases

Office Action

§102 §103 §DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment 2. This action is responsive to the amendments filed 2/24/2026. Claims 1, 4, 7, 11, 13, 15, 19, 36, 38-40, 42-44, and 46-49 have been amended. No claims were newly added. Claims 28-31, 33-35, and 50-64 have been canceled. Response to Arguments 3. The amendments have overcome the double patenting rejection therefore the double patenting rejection has been withdrawn. Applicant’s response with respect to the art rejections have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-2 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Muller et al. (US Pub.: 2020/0164125 A1). Regarding claim 1, Muller discloses a mechanical circulatory support system (e.g. paragraph 0002), comprising: a circulatory support catheter (e.g. Fig. 4 – catheter assembly 100A; paragraph 0054), comprising a circulatory support device (e.g. Fig. 4 – impeller assembly 116A) carried by an elongate flexible catheter shaft (e.g. Fig. 4 – elongate body 174A), the circulatory support device comprising a tubular housing (e.g. Fig. 4 – housing 1401), a motor (e.g. paragraphs 0054-0055), and an impeller configured to be rotated by the motor (e.g. Fig. 4 – impeller assembly 116A; paragraph 0055); an insertion tool having a tubular body (e.g. Fig. 13 – guidewire guide tube 312) configured to axially movably receive the circulatory support device with an insertion tool lumen of the insertion tool (e.g. paragraph 0087); and an introducer sheath (e.g. Fig. 13 – cannula housing 302) having a tubular body configured to axially movably receive, within an introducer sheath lumen of the introducer sheath, the insertion tool while the insertion tool has the circulatory support device therein (e.g. paragraph 0087), wherein both the insertion tool and introducer sheath, while the insertion tool having the circulatory support device therein is within the introducer sheath, are configured to extend at least partially distal to an arterial access point (e.g. (e.g. paragraphs 0087-0088). Regarding claim 2, Muller discloses the system of claim 1 as discussed above, and Muller further discloses wherein the impeller is configured to be rotated by the motor via a shaft (e.g. paragraphs 0055, 0064). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 3-4, 6 and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Muller and further in view of Siess et al. (US Patent No. 6,794,789, hereafter referred to as “Siess ‘789” – Previously Cited). Regarding claim 3, Muller discloses the system of claim 2 as discussed above. However, Muller does not explicitly teach wherein the circulatory support device comprises an annular polymeric seal around the shaft. Siess ‘789, in a same field of endeavor of circulatory/catheter devices, discloses an intravascular blood pump, which is a circulatory support device, with an annular polymeric seal around the shaft (e.g. col. 2 lines 49-52, Fig. 2, sealing bearing 21). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to incorporate an annular polymeric seal around the shaft, as taught and suggested by Siess ‘789, in order to decrease the likelihood of blood leakage through use of an effective seal placement. Regarding claim 4, Muller teaches the system of claim 2 as discussed above. However, Muller does not explicitly teach wherein the circulatory support device comprises a seal around the shaft. Siess ‘789, in a same field of endeavor of circulatory/catheter devices, discloses an intravascular blood pump, which is a circulatory support device, with a seal around the shaft (e.g. col. 2 lines 49-52, Fig. 2, sealing bearing 21). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to incorporate a seal around the shaft, as taught and suggested by Siess ‘789, in order to decrease the likelihood of blood leakage through use of an effective seal placement. Regarding claim 6, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach wherein the impeller is configured to be rotated by the motor via a magnetic coupling. Siess ‘789, in a same field of endeavor of circulatory/catheter devices, discloses an intravascular blood pump wherein the impeller is configured to be rotated by the motor via a magnetic coupling (e.g. abstract, col. 1 lines 19-28, col. 2 lines 43-52, – magnetic coupling 53). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to incorporate a magnetic coupling, as taught and suggested by Siess ‘789, because magnetic couplings are popular in the art of blood pumps in order to reduce friction between moving parts. Regarding claim 19, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach wherein the tubular housing of the circulatory support device comprises an inlet tube coupled with a motor housing, the inlet tube having one or more distal pump inlets and one or more proximal pump outlets, and the impeller adjacent the one or more proximal pump outlets. Siess ‘789, in a same field of endeavor of circulatory/catheter devices, discloses wherein the tubular housing of a circulatory support device comprises an inlet tube coupled with a motor housing, the inlet tube having one or more distal pump inlets and one or more proximal pump outlets, and the impeller adjacent the one or more proximal pump outlets (e.g. col. 3 line 48 – col. 4 lines 1-2, Figs. 1-2; the inlet is a tube because it is in a tubular shape around the pump, and the motor is in the housing, abstract). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to incorporate the modifications of the motor housing and pump inlets and outlets, as taught and suggested by Siess ‘789, in order to improve the efficiency of the device. Claims 7-12 and 23-27 are rejected under 35 U.S.C 103 as being unpatentable over Muller and further in view of Schumacher et al. (US Pub.: 2015/0343179 A1, – Previously Cited). Regarding claim 7, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach wherein the introducer sheath comprises a hub on a proximal end of the introducer sheath, the hub having a feature for preventing axial and rotational movement of the insertion tool. Schumacher, in a same field of endeavor of catheters, discloses wherein the introducer sheath comprises a hub on a proximal end of the introducer sheath, the hub having a feature for preventing axial and rotational movement of the insertion tool (e.g. paragraph 0140) Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to include a hub on a proximal end of the introducer sheath, the hub having a feature for preventing axial and rotational movement of the insertion tool, as taught and suggested by Schumacher, in order to make the catheter more secure during insertion procedures (Schumacher, paragraph 0140). Regarding claim 8, Muller in view of Schumacher teaches the system of claim 7 as discussed above, and Schumacher further teaches the hub comprising one or more hemostatic valves (e.g. paragraph 0061). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Muller and Schumacher to include the hub comprising one or more hemostatic valves, as taught and suggested by Schumacher, in order to control where fluid escapes from the catheter’s lumen (Schumacher, paragraph 0061). Regarding claim 9, Muller in view of Schumacher teaches the system of claim 8 as discussed above, and Schumacher further teaches wherein the tubular body of the insertion tool has sufficient collapse resistance to maintain patency when passed through the one or more hemostatic valves of the introducer sheath (e.g. Fig. 15 – the parts can be clamped in place, therefore it has sufficient resistance to maintain patency; paragraph 0132). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Muller and Schumacher to include wherein the tubular body of the insertion tool has sufficient collapse resistance to maintain patency when passed through the one or more hemostatic valves of the introducer sheath, as taught and suggested by Schumacher, in order to ensure that the catheter can be safely used for as long as possible (Schumacher, paragraph 0011). Regarding claim 10, Muller in view of Schumacher teaches the system of claim 7 as discussed above, and Schumacher further teaches wherein the hub and a relief bend disposed between the hub and the tubular body of the introducer sheath are configured to axially movably receive the tubular body of the insertion tool (e.g. Fig. 17 – relief bend is sloped edge on element 114). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Muller and Schumacher to have the hub and a relief bend disposed between the hub and the tubular body of the introducer sheath are configured to axially movably receive the tubular body of the insertion tool, as taught and suggested by Schumacher, in order to allow for more efficient movement of the insertion tool. Regarding claim 11, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach that the insertion tool comprises a tube with a valve in fluid communication with the insertion tool lumen of the tubular body of the insertion tool configured for flushing with saline. Schumacher, in a same field of endeavor of catheters, discloses that the insertion tool comprises a tube with a valve in fluid communication with the insertion tool lumen of the tubular body of the insertion tool configured for flushing with saline (e.g. paragraph 0136, – auxiliary sheath 104 has flushing device 109 which is a flushing tube and an opening in the wall of housing 113). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to include wherein the insertion tool comprises a tube with a valve in fluid communication with the insertion tool lumen of the tubular body of the insertion tool configured for flushing with saline, as taught and suggested by Schumacher, for the purpose of maintaining a sterile environment while using the device (Schumacher, paragraph 0136). Regarding claim 12, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach that the catheter shaft comprises a visual marker spaced proximally from the circulatory support device such that visibility of the visual marker on a proximal side of the introducer sheath indicates the circulatory support device is located within the tubular body of the insertion tool. Schumacher, in a same field of endeavor of catheters, discloses that the catheter shaft comprises a visual marker spaced proximally from the circulatory support device such that visibility of the visual marker on a proximal side of the introducer sheath indicates the circulatory support device is located within the tubular body of the insertion tool (e.g. paragraph 0114, visible marking 78 on element 76). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to include wherein the catheter shaft comprises a visual marker spaced proximally from the circulatory support device such that visibility of the visual marker on a proximal side of the introducer sheath indicates the circulatory support device is located within the tubular body of the insertion tool, as taught and suggested by Schumacher, in order to make it easier to identify a target position for clamping (Schumacher, paragraph 0114). Regarding claim 23, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach wherein the insertion tool comprises a hemostatic valve. Schumacher, in a same field of endeavor of catheters, discloses wherein the insertion tool comprises a hemostatic valve (e.g. paragraph 0061). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to include having the insertion tool comprise a hemostatic valve, as taught and suggested by Schumacher, in order to control where fluid escapes from the insertion tool (Schumacher, paragraph 0061). Regarding claim 24, Muller teaches the system of claim 1 as discussed above. However, Muller does not explicitly teach that the insertion tool comprises a plug disposed at a proximal end of the insertion tool configured to connect to a sterile shield sleeve. Schumacher, in a same field of endeavor of catheters, discloses that the insertion tool comprises a plug disposed at a proximal end of the insertion tool configured to connect to a sterile shield sleeve (e.g., paragraphs 0145-0147, – plug disposed at proximal end of insertion tool configured to connect to sterile shield sleeve). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to include that the insertion tool comprises a plug disposed at a proximal end of the insertion tool configured to connect to a sterile shield sleeve, as taught and suggested by Schumacher, for the purpose of maintaining the sterility of the tube in a fluid-tight environment (Schumacher, paragraph 0145). Regarding claim 25, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach that the insertion tool comprises a locking mechanism, the locking mechanism comprising a recess configured to accept a locking pad configured to releasably lock with the circulatory support catheter. Schumacher, in a same field of endeavor of catheters, discloses that the insertion tool comprises a locking mechanism, the locking mechanism comprising a recess configured to accept a locking pad configured to releasably lock with the circulatory support catheter (e.g. paragraph 0127, Fig. 14, clamping device can be clamped so that smaller diameter catheter is clamped in receiving space, which is the recess, using radial compression of clamping ring 56’). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to include that the insertion tool comprises a locking mechanism, the locking mechanism comprising a recess configured to accept a locking pad configured to releasably lock with the circulatory support catheter, as taught and suggested by Schumacher, for the purpose of allowing the smaller diameter catheter to be clamped in the receiving space using radial compression (Schumacher, paragraph 0127). Regarding claim 26, Muller in view of Schumacher teaches the system of claim 25 as discussed above, and Schumacher further teaches that the insertion tool comprises a housing surrounding at least a portion of the locking mechanism, the housing comprising opposing first inner surface walls spaced farther than opposing second inner surface walls, wherein the at least a portion of the locking mechanism comprises radially outwardly extending tabs, and wherein the housing is configured to rotate to inwardly compress the tabs to prevent axial movement of the circulatory support catheter (e.g. paragraph 0123, clamping device has flexible clamping ring 56’, which is conical and forced against mechanical stop 57’; axial pressure is exerted on clamping ring by pressure screws, and by screwing in the device; the screw threads are radially outwardly extending tabs; Fig. 13c, paragraph 0114 depicts beads which are radially outwardly extending tabs, for clamping, but they can also be screwed, that is rotated, to inwardly compress the tabs to prevent axial movement.). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Muller and Schumacher to include that the insertion tool comprises a housing surrounding at least a portion of the locking mechanism, the housing comprising opposing first inner surface walls spaced farther than opposing second inner surface walls, wherein the at least a portion of the locking mechanism comprises radially outwardly extending tabs, and wherein the housing is configured to rotate to inwardly compress the tabs to prevent axial movement of the circulatory support catheter, as taught and suggested by Schumacher, for the purpose of making the insertion tool more secure while it is in use (Schumacher, paragraphs 0114, 0123) Regarding claim 27, Muller in view of Schumacher teaches the system of claim 26 as discussed above, and Schumacher further teaches wherein inward compression of the tabs of the locking mechanism compresses the locking pad against the circulatory support catheter (e.g. paragraphs 0114, 0123). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Muller and Schumacher to include wherein inward compression of the tabs of the locking mechanism compresses the locking pad against the circulatory support catheter, as taught and suggested by Schumacher, in order to further improve the security of the insertion device while it is in use. Claims 13-16 are rejected under 35 U.S.C 103 as being unpatentable over Muller and further in view of Muller et al. (US Patent No.: 10,449,279 B2) (hereinafter “Muller ‘279”). Regarding claim 13, Muller discloses the system of claim 1 as discussed above, and Muller further teaches a first guidewire port on a distal end of the tubular housing of the circulatory support device (e.g. Fig. 16 – distal opening 338; paragraph 0105). However, Muller does not explicitly teach a second guidewire port on a sidewall of the tubular housing of the circulatory support device and distal to the impeller. Muller ‘279, in a same field of endeavor of catheter devices, discloses a second guidewire port on a sidewall of the tubular housing of the circulatory support device and distal to the impeller (e.g. Fig. 16, see annotated figure below; column 23, lines 16-30). PNG media_image1.png 544 401 media_image1.png Greyscale Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller to place the second guidewire port on a sidewall of the tubular housing of the circulatory support device and distal to the impeller, in order to bypass the pump with the guidewire, and not have the guidewire passing through the impeller. The reason is to reduce the profile of the device by eliminating the need for a guidewire channel through the middle of the device (Muller ‘279, column 23, lines 16-35). Regarding claim 14, Muller in view of Muller ‘279 teaches the system of claim 13 as discussed above, and Muller further teaches wherein a distal end of the tubular body of the insertion tool detachably connects to a guidewire aid configured to facilitate entry of a guidewire through the first guidewire port (e.g. paragraphs 0105). Regarding claim 15, Muller in view of Muller ‘279 teaches the system of claim 13 as discussed above, and Muller ‘279 further teaches wherein a removable guidewire guide tube enters the first guidewire port on the distal end of the tubular housing, and exits the tubular housing via the second guidewire port on the sidewall of the tubular housing distal to the impeller (e.g. column 22, lines 45-54; column 23, lines 16-35). Regarding claim 16, Muller in view of Muller ‘279 teaches the system of claim 15 as discussed above, and Muller further teaches wherein the tubular body of the insertion tool is configured to receive the circulatory support device with the removable guidewire guide tube (e.g. paragraph 0105). Claim 17 is rejected under 35 U.S.C. 103 as being unpatentable over Muller and further in view of Muller ‘279 and further in view of Yokota et al. (US Patent No.: 11,291,800 B2, – Previously Cited). Regarding claim 17, Muller in view of Muller ‘279 teaches the system of claim 16 as discussed above. However, Muller in view of Muller ‘279 does not explicitly teach wherein the tubular body of the insertion tool and the guidewire guide tube are transparent. Yokota, in a same field of endeavor of catheters, discloses wherein the tubular body of the insertion tool and the guidewire guide tube are transparent (e.g. column 6, lines 6-15). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Muller and Muller ‘279 to incorporate the modifications of making the tubular body of the insertion tool and the guidewire guide tube transparent, as taught and suggested by Yokota, in order to make it easier for the user to visually confirm blood (e.g. flashback) as well as to be able to use optical imaging modalities to see the placement of the guidewire in the tube. Claim 18 is rejected under 35 U.S.C. 103 as being unpatentable over Muller and further in view of Scheckel et al. (US Pub.: 2020/0139028 A1, – Previously Cited). Regarding claim 18, Muller discloses the system of claim 1 as discussed above, and Muller further teaches wherein the tubular body of the insertion tool has an inside diameter of the insertion tool within a range of about 4.5 mm to about 6.5 mm (e.g. paragraph 0050, – about 12.5 FR). However, Muller does not explicitly teach wherein the tubular body of the insertion tool has a length within a range of from about 85 mm to about 160 mm. Scheckel, in a same field of endeavor of catheters, teaches that for a flexible catheter for putting a blood pump into the heart (e.g. abstract), wherein the distal end, which corresponds to the tubular body of the insertion tool, has a length within a range of about 85 mm to about 160 mm (e.g. paragraph 0072, – distal end about 13.5 cm long). It would have been obvious to one having ordinary skill in the art to modify the system of Muller with a teaching of the tubular body of the insertion tool having a length within a range of about 85 mm to about 160 mm in order to use a short catheter that may easily navigate through bodily lumina of people of all sizes, without being too bulky. Claim 20 is rejected under 35 U.S.C. 103 as being unpatentable over Muller and further in view of Siess et al. (US Pub.: 2017/0043074 A1, hereafter referred to as “Siess ‘074”, – Previously Cited). Regarding claim 20, Muller teaches the system of claim 1 as discussed above. However, Muller does not explicitly teach whether the system requires purging. Siess ‘074, in a same field of endeavor of catheters, teaches that a miniature blood pump may be designed not to require purging (e.g. paragraph 0006). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the system of Muller with Siess ‘074’s teachings to incorporate design elements such that the system does not require purging, in order to make the design smaller by eliminating the need to use a purge fluid. Claims 21-22 are rejected under 35 U.S.C. 103 as being unpatentable over Muller and further in view of Rau et al. (US Patent No.: 6,176,848, – Previously Cited). Regarding claim 21, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach the exact dimensions of the introducer sheath. Rau, in a same field of endeavor of catheters, teaches a minimally invasive blood pump with an introducer sheath size of 16 French (Fr) sheath (e.g. col. 1 lines 59-63, pump diameter restricted to 5-7 mm, which incorporates an outer diameter of 16 French, which is 5.33 mm). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to incorporate Rau’s teaching into the system of Muller in order to ensure that the device passes easily through the user’s blood vessels. Regarding claim 22, Muller discloses the system of claim 1 as discussed above. However, Muller does not explicitly teach a flow rate of a circulatory support device to be used with the system. Rau, in a same field of endeavor of catheters, teaches a minimally invasive circulatory support device with a flow rate of about 4.0 liters per minute (e.g. col. 1 lines 63-65). Rau does not specify a time limitation on the pump. It would have been obvious to one having ordinary skill in the art to apply Rau’s teaching of flow rate to the system of Muller in order to successfully treat cardiac problems. Since Rau does not teach a time limitation on the operation of the pump, it would further have been obvious to one having ordinary skill in the art to use Rau’s pump to provide this flow rate for about 6 hours, in order to provide the patient treatment for a clinically significant period of time. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DANIEL TEHRANI whose telephone number is (571)270-0697. The examiner can normally be reached 9:00am-5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached at 571-270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /D.T./Examiner, Art Unit 3792 /Benjamin J Klein/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Nov 18, 2021
Application Filed
Aug 04, 2024
Non-Final Rejection — §102, §103, §DP
Nov 08, 2024
Response Filed
Feb 01, 2025
Final Rejection — §102, §103, §DP
May 12, 2025
Request for Continued Examination
May 14, 2025
Response after Non-Final Action
Sep 06, 2025
Non-Final Rejection — §102, §103, §DP
Feb 24, 2026
Response Filed
Mar 27, 2026
Final Rejection — §102, §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599764
HEADER ASSEMBLY HAVING CONTROLLED THERAPEUTIC AGENT RELEASE
2y 5m to grant Granted Apr 14, 2026
Patent 12558546
DORSAL ROOT GANGLION STIMULATION IN INFLUENCING ORGAN FUNCTION
2y 5m to grant Granted Feb 24, 2026
Patent 12539420
Deep Brain Stimulation Using Artificial Neural Networks
2y 5m to grant Granted Feb 03, 2026
Patent 12508432
Configurable Replacement Mechanism for Leadless Pacemaker System
2y 5m to grant Granted Dec 30, 2025
Patent 12502238
SURGICAL APPARATUS INCLUDING A STERILE ADAPTER HAVING MECHANICAL LOCKOUTS
2y 5m to grant Granted Dec 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
58%
Grant Probability
99%
With Interview (+43.8%)
3y 9m
Median Time to Grant
High
PTA Risk
Based on 48 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month